TY - JOUR
T1 - The Evolution of Science and Regulation of Dietary Supplements
T2 - Past, Present, and Future
AU - Coates, Paul M.
AU - Bailey, Regan L.
AU - Blumberg, Jeffrey B.
AU - El-Sohemy, Ahmed
AU - Floyd, Elizabeth
AU - Goldenberg, Joshua Z.
AU - Gould Shunney, Aimée
AU - Holscher, Hannah D.
AU - Nkrumah-Elie, Yasmeen
AU - Rai, Deshanie
AU - Ritz, Barry W.
AU - Weber, Wendy J.
N1 - HDH has received grant funding from the Almond Board of California, Bio-Cat, Danone Research, General Mills, Hass Avocado Board, Tate & Lyle, National Honey Board, and USDA.
All speakers, except for YN-E, DR, BWR, and WJW, received travel support and honoraria from CRN to participate in the symposium. PMC received financial support from CRN to write and organize the publication of this manuscript. RLB is supported by 2R01CA215834-05A1. JBB receives support from the Food is Medicine Institute, Friedman School of Nutrition Science and Policy, Tufts University. AE-S has held grants from the Canadian Institutes of Health Research, the Advanced Foods and Materials Network Center of Excellence, the Allen Foundation, and the Canadian Foundation for Dietetic Research for projects on personalized nutrition. ZEF is supported by NIH grant P50AT002776. JZG is supported by NIH grants R25DK130848 and R90AT008924. AGS did not receive additional funding from any agency in the public, commercial, or not-for-profit sectors for this work. HDH has received grant funding from the Almond Board of California, Bio-Cat, Danone Research, General Mills, Hass Avocado Board, Tate & Lyle, National Honey Board, and USDA. DR received travel support from OmniActive Health Technologies. WJW reports no sources of support.
AE-S has held grants from the Canadian Institutes of Health Research, the Advanced Foods and Materials Network Center of Excellence, the Allen Foundation, and the Canadian Foundation for Dietetic Research for projects on personalized nutrition.
ZEF is supported by NIH grant P50AT002776.
JZG is supported by NIH grants R25DK130848 and R90AT008924.
PY - 2024/8
Y1 - 2024/8
N2 - Dietary supplement use in the United States is widespread and increasing, especially among certain population groups, such as older Americans. The science surrounding dietary supplements has evolved substantially over the last few decades since their formal regulation in 1994. Much has been learned about the mechanisms of action of many dietary supplement ingredients, but the evidence on their health effects is still building. As is true of much nutrition research, there are many studies that point to health effects, but not all are at the level of scientific evidence (e.g., randomized controlled interventions), rigor, or quality needed for definitive statements of efficacy regarding clinical end points. New technologies and approaches are being applied to the science of dietary supplements, including nutrigenomics and microbiome analysis, data science, artificial intelligence (AI), and machine learning—all of which can elevate the science behind dietary supplements. Products can contain an array of bioactive compounds derived from foods as well as from medicinal plants, which creates enormous challenges in data collection and management. Clinical applications, particularly those aimed at providing personalized nutrition options for patients, have become more sophisticated as dietary supplements are incorporated increasingly into clinical practice and self-care. The goals of this article are to provide historical context for the regulation and science of dietary supplements, identify research resources, and suggest some future directions for science in this field.
AB - Dietary supplement use in the United States is widespread and increasing, especially among certain population groups, such as older Americans. The science surrounding dietary supplements has evolved substantially over the last few decades since their formal regulation in 1994. Much has been learned about the mechanisms of action of many dietary supplement ingredients, but the evidence on their health effects is still building. As is true of much nutrition research, there are many studies that point to health effects, but not all are at the level of scientific evidence (e.g., randomized controlled interventions), rigor, or quality needed for definitive statements of efficacy regarding clinical end points. New technologies and approaches are being applied to the science of dietary supplements, including nutrigenomics and microbiome analysis, data science, artificial intelligence (AI), and machine learning—all of which can elevate the science behind dietary supplements. Products can contain an array of bioactive compounds derived from foods as well as from medicinal plants, which creates enormous challenges in data collection and management. Clinical applications, particularly those aimed at providing personalized nutrition options for patients, have become more sophisticated as dietary supplements are incorporated increasingly into clinical practice and self-care. The goals of this article are to provide historical context for the regulation and science of dietary supplements, identify research resources, and suggest some future directions for science in this field.
KW - bioactive components
KW - botanical extracts
KW - dietary supplements
KW - gut microbiome
KW - integrative health
KW - micronutrients
KW - nutrigenomics
KW - prebiotics
KW - precision nutrition
KW - recommended nutrient intakes
UR - http://www.scopus.com/inward/record.url?scp=85199149821&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85199149821&partnerID=8YFLogxK
U2 - 10.1016/j.tjnut.2024.06.017
DO - 10.1016/j.tjnut.2024.06.017
M3 - Article
C2 - 38971530
AN - SCOPUS:85199149821
SN - 0022-3166
VL - 154
SP - 2335
EP - 2345
JO - Journal of Nutrition
JF - Journal of Nutrition
IS - 8
ER -